ESRD (END STAGE RENAL DISEASE)
Clinical trials for ESRD (END STAGE RENAL DISEASE) explained in plain language.
Never miss a new study
Get alerted when new ESRD (END STAGE RENAL DISEASE) trials appear
Sign up with your email to follow new studies for ESRD (END STAGE RENAL DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for dialysis patients: drug AP301 targets dangerous phosphorus levels
Disease control CompletedThis study tested a new drug called AP301 in 474 adults with end-stage kidney disease on dialysis who have high phosphorus levels. The goal was to see if AP301 can safely lower phosphorus better than the current standard treatment, sevelamer carbonate. Participants received eithe…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
AI could predict dialysis complications before they happen
Knowledge-focused CompletedThis study looked at health records from 778 adults on long-term hemodialysis to see if artificial intelligence could predict serious complications like heart disease or stroke. Researchers used past data to build computer models that might give early warnings. The goal was to he…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC
-
New device may help dialysis patients by tracking fluid removal
Knowledge-focused CompletedThis study tested a new device called HemoCept to see if it can accurately measure fluid changes during dialysis. 26 adults with end-stage kidney disease who were on dialysis for over 90 days took part. The goal was to see if the device's readings matched the amount of fluid remo…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC
-
Can a gadget improve dialysis? small study says maybe
Knowledge-focused CompletedThis small pilot study tested a device called HemoCept to see if it can accurately track fluid changes during dialysis. 12 adults with end-stage kidney disease took part. The goal was to see if the device's readings matched how much fluid was removed during treatment. No major he…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC